251 related articles for article (PubMed ID: 32018211)
1. High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3.
Guo R; Liu N; Liu H; Zhang J; Zhang H; Wang Y; Baruscotti M; Zhao L; Wang Y
Phytomedicine; 2020 Mar; 68():153171. PubMed ID: 32018211
[TBL] [Abstract][Full Text] [Related]
2. A machine learning-driven study indicates emodin improves cardiac hypertrophy by modulation of mitochondrial SIRT3 signaling.
Gao J; Zhang K; Wang Y; Guo R; Liu H; Jia C; Sun X; Wu C; Wang W; Du J; Chen J
Pharmacol Res; 2020 May; 155():104739. PubMed ID: 32135248
[TBL] [Abstract][Full Text] [Related]
3. SIRT3 inhibits cardiac hypertrophy by regulating PARP-1 activity.
Feng X; Wang Y; Chen W; Xu S; Li L; Geng Y; Shen A; Gao H; Zhang L; Liu S
Aging (Albany NY); 2020 Mar; 12(5):4178-4192. PubMed ID: 32139662
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner.
Meng G; Liu J; Liu S; Song Q; Liu L; Xie L; Han Y; Ji Y
Br J Pharmacol; 2018 Apr; 175(8):1126-1145. PubMed ID: 28503736
[TBL] [Abstract][Full Text] [Related]
5. NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy.
Yue Z; Ma Y; You J; Li Z; Ding Y; He P; Lu X; Jiang J; Chen S; Liu P
Exp Cell Res; 2016 Oct; 347(2):261-73. PubMed ID: 27423420
[TBL] [Abstract][Full Text] [Related]
6. Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3.
Pillai VB; Samant S; Sundaresan NR; Raghuraman H; Kim G; Bonner MY; Arbiser JL; Walker DI; Jones DP; Gius D; Gupta MP
Nat Commun; 2015 Apr; 6():6656. PubMed ID: 25871545
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
Ding YQ; Zhang YH; Lu J; Li B; Yu WJ; Yue ZB; Hu YH; Wang PX; Li JY; Cai SD; Ye JT; Liu PQ
Acta Pharmacol Sin; 2021 Sep; 42(9):1422-1436. PubMed ID: 33247214
[TBL] [Abstract][Full Text] [Related]
8. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
9. Receptor-interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes.
You J; Yue Z; Chen S; Chen Y; Lu X; Zhang X; Shen P; Li J; Han Q; Li Z; Liu P
Acta Physiol (Oxf); 2017 May; 220(1):58-71. PubMed ID: 27614093
[TBL] [Abstract][Full Text] [Related]
10. Baicalin inhibits pressure overload-induced cardiac hypertrophy by regulating the SIRT3-dependent signaling pathway.
Cai Y; Jiang S; Huang C; Shen A; Zhang X; Yang W; Xiao Y; Gao S; Du R; Zheng G; Yan T; Craig Wan C
Phytomedicine; 2023 Jun; 114():154747. PubMed ID: 36931095
[TBL] [Abstract][Full Text] [Related]
11. Exogenous NADPH exerts a positive inotropic effect and enhances energy metabolism via SIRT3 in pathological cardiac hypertrophy and heart failure.
Qian K; Tang J; Ling YJ; Zhou M; Yan XX; Xie Y; Zhu LJ; Nirmala K; Sun KY; Qin ZH; Sheng R
EBioMedicine; 2023 Dec; 98():104863. PubMed ID: 37950995
[TBL] [Abstract][Full Text] [Related]
12. FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214 / SIRT3 signaling pathway.
Zhang Y; Sun M; Wang D; Hu Y; Wang R; Diao H; Shao X; Li Y; Li X; Leng M; Wang L; Yan M; Rong X; Guo J
Biomed Pharmacother; 2022 Apr; 148():112696. PubMed ID: 35183007
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
Guo L; Yin A; Zhang Q; Zhong T; O'Rourke ST; Sun C
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H980-H991. PubMed ID: 28411231
[TBL] [Abstract][Full Text] [Related]
14. SZC-6, a small-molecule activator of SIRT3, attenuates cardiac hypertrophy in mice.
Li ZY; Lu GQ; Lu J; Wang PX; Zhang XL; Zou Y; Liu PQ
Acta Pharmacol Sin; 2023 Mar; 44(3):546-560. PubMed ID: 36042291
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Sirtuin-3 (SIRT3) Prevents Doxorubicin-Induced Dilated Cardiomyopathy by Modulating Protein Acetylation and Oxidative Stress.
Tomczyk MM; Cheung KG; Xiang B; Tamanna N; Fonseca Teixeira AL; Agarwal P; Kereliuk SM; Spicer V; Lin L; Treberg J; Tong Q; Dolinsky VW
Circ Heart Fail; 2022 May; 15(5):e008547. PubMed ID: 35418250
[TBL] [Abstract][Full Text] [Related]
16. Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice.
Pillai VB; Bindu S; Sharp W; Fang YH; Kim G; Gupta M; Samant S; Gupta MP
Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H962-72. PubMed ID: 26873966
[TBL] [Abstract][Full Text] [Related]
17. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
[TBL] [Abstract][Full Text] [Related]
18. 2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis.
Peng F; Liao M; Jin W; Liu W; Li Z; Fan Z; Zou L; Chen S; Zhu L; Zhao Q; Zhan G; Ouyang L; Peng C; Han B; Zhang J; Fu L
Signal Transduct Target Ther; 2024 May; 9(1):133. PubMed ID: 38744811
[TBL] [Abstract][Full Text] [Related]
19. Network pharmacology integrated with experimental validation to elucidate the mechanisms of action of the Guizhi-Gancao Decoction in the treatment of phenylephrine-induced cardiac hypertrophy.
Yang K; Shan X; Songru Y; Fu M; Zhao P; Guo W; Xu M; Chen H; Lu R; Zhang C
Pharm Biol; 2024 Dec; 62(1):456-471. PubMed ID: 38773737
[TBL] [Abstract][Full Text] [Related]
20. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
Evans LW; Bender A; Burnett L; Godoy L; Shen Y; Staten D; Zhou T; Angermann JE; Ferguson BS
J Nutr Biochem; 2020 May; 79():108339. PubMed ID: 32007664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
